Market Access 2024

Exploring the art and science of getting medicines from lab to patient

Click here

Chasing the holy grail of value-based healthcare

With healthcare costs spiralling upwards, a new approach is emerging: value-based care. Trace the history of this this transformative movement to find out how pioneers are flipping the script to achieve better outcomes for patients

Click here

Rare diseases: the urgent need for health equity and accelerated access

While rare diseases present complex challenges, there’s a critical need for solutions. Alexion’s Eunice Alvazzi explores how we can all work together to ensure access to innovative treatments for rare diseases

Click here

The pharma world at your fingertips

Daily and weekly email newsletters from pharmaphorum – insights and analysis on the big trends shaping healthcare and the pharmaceutical industry

Click here

The biosimilars dance: how drugmakers game the US patent system

With blockbuster biologics set to lose patent protection by 2030, biosimilars offer a glimmer of hope. But, will complex patent strategies stand in the way? Deep Dive’s Eloise McLennan explores the intricate dance between innovation and affordability

Click here

The UK vs. superbugs: Combatting AMR on the homefront

Antimicrobial resistance has been hailed as one of the biggest pharma challenges in this century. So how are nations tackling this behemoth threat to public health? Nicole Raleigh spotlights the UK’s approach

Click here

Overcoming AMR market failure: Three start-up stories

We need new antibiotics to tackle the slow-brewing AMR crisis, but with little short term financial incentive to fuel innovation, few are willing to take the risk. Jonah Comstock talks to three tenacious start-ups tackling AMR in their own ways

Click here

Integrating market access considerations into biopharmaceutical asset investment decisions

Explore how integrating market access insights from inception through clinical trials ensures both the efficacy and commercial success of new therapies as Putnam (part of Inizio Advisory) examines common pain points and best practices

Click here

The pharmaphorum podcast

Download exclusive interviews and discussions with senior pharma and biotech executives

Click here

Mind the gap: What is causing the ongoing ADHD drug shortage?

Millions of patients rely on ADHD therapeutics to manage their symptoms, but supply disruptions have left many struggling to access their medication. Jonah Comstock delves into the complex causes and consequences of the ongoing shortages

Click here

Heard on the pipeline: Access to medication

Join pharmaphorum’s Jonah Comstock as he grills industry experts at Reuters Pharma US on the systemic issues hindering medication access and affordability worldwide

Click here

Around the world in pharma events

Keep up to date with important industry events taking place across the pharmaceutical industry with this interactive guide to upcoming conferences around the globe

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send